⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL77435 | 0.76 | — | — | |
| SCHEMBL31023748 | 0.74 | — | — | |
| SCHEMBL9115247 | 0.74 | — | — | |
| SCHEMBL28831575 | 0.74 | — | — | |
| SCHEMBL7162000 | 0.74 | — | — | |
| SCHEMBL11261794 | 0.74 | — | — | |
| SCHEMBL9810989 | 0.74 | — | — | |
| Hydrochloric Acid SCHEMBL11109028 | 0.74 | — | — | |
| Ammonia Solution, Strong SCHEMBL11560599 | 0.74 | — | — | |
| SCHEMBL28345968 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10903522-B2 | Phosphonate based lithium complexes | BASF SE (DE) | 2021-01-26 | — | — | US | disclosed |
| EP-3516724-B1 | PHOSPHONATE BASED LITHIUM COMPLEXES | BASF SE (DE) | 2020-09-02 | — | — | EP | disclosed |
| US-20190252723-A1 | PHOSPHONATE BASED LITHIUM COMPLEXES | BASF SE (DE) | 2019-08-15 | — | — | US | disclosed |
| EP-3516724-A1 | PHOSPHONATE BASED LITHIUM COMPLEXES | BASF SE (DE) | 2019-07-31 | — | — | EP | disclosed |
| WO-2018054710-A1 | PHOSPHONATE BASED LITHIUM COMPLEXES | BASF SE (DE) | 2018-03-29 | — | — | WO | disclosed |
| US-6131226-A | 2-SUBSTITUTED,3,5-BIS(METHOXYCARBONYL),4-(2,6-DIHALOPHENYL), 6-(1-((SUBSTITUTED)RING)PIPERAZIN-1,4-YLENE-CARBONYLMETHYL)-1, 4-DIHYDROPYRIDINES; FOR TREATING INFLAMMATION, PAIN, VIRAL INFECTIONS, CARDIOVASCULAR DISEASE, ALLERGIES, ASTHMA | PFIZER INC. (US) | 2000-10-17 | — | — | US | disclosed |
| EP-0563096-B1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 2000-05-03 | — | — | EP | disclosed |
| US-5438048-A | Used for treatment of disorders related to metabolism of calcium and other bivalent metals; treats bone cancer, urolithiasis, rheumatoid arthritis, bone infection and bone degradation | LEIRAS OY (FI) | 1995-08-01 | — | — | US | disclosed |
| EP-0563096-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1993-10-06 | — | — | EP | disclosed |
| WO-1992011267-A1 | NOVEL METHYLENEBISPHOSPHONIC ACID DERIVATIVES | LEIRAS OY (FI) | 1992-07-09 | — | — | WO | disclosed |